These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34256778)

  • 1. LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.
    Mehta R; Elías-López D; Martagón AJ; Pérez-Méndez OA; Sánchez MLO; Segura Y; Tusié MT; Aguilar-Salinas CA
    Lipids Health Dis; 2021 Jul; 20(1):70. PubMed ID: 34256778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.
    Vitali C; Bajaj A; Nguyen C; Schnall J; Chen J; Stylianou K; Rader DJ; Cuchel M
    J Lipid Res; 2022 Mar; 63(3):100169. PubMed ID: 35065092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
    Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pathogenic variant in LCAT causing FLD. A case report.
    Goñi Ros N; González-Tarancón R; Sienes Bailo P; Salvador-Ruperez E; Puzo Bayod M; Puzo Foncillas J
    Acta Clin Belg; 2022 Dec; 77(6):970-975. PubMed ID: 34789074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase.
    Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
    J Lipid Res; 1995 May; 36(5):967-74. PubMed ID: 7658168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM; Sallee B; Asztalos BF; Pritchard PH; Frohlich J; Schaefer EJ
    J Clin Lipidol; 2014; 8(2):223-30. PubMed ID: 24636183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges.
    Vitali C; Rader DJ; Cuchel M
    Curr Opin Lipidol; 2023 Apr; 34(2):35-43. PubMed ID: 36473023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review.
    Shoji K; Morita H; Ishigaki Y; Rivard CJ; Takayasu M; Nakayama K; Nakayama T; Inoue Y; Ayaki M; Yoshimura A
    Clin Nephrol; 2011 Oct; 76(4):323-8. PubMed ID: 21955868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lecithin: cholesterol acyltransferase (LCAT)--the genetic analysis of familial LCAT deficiency and fish eye disease].
    Bujo H; Saito Y
    Nihon Rinsho; 1995 May; 53(5):1260-6. PubMed ID: 7602789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes.
    Kuivenhoven JA; Pritchard H; Hill J; Frohlich J; Assmann G; Kastelein J
    J Lipid Res; 1997 Feb; 38(2):191-205. PubMed ID: 9162740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LCAT deficiency: a nephrological diagnosis].
    Boscutti G; Calabresi L; Pizzolitto S; Boer E; Bosco M; Mattei PL; Martone M; Milutinovic N; Berbecar D; Beltram E; Franceschini G
    G Ital Nefrol; 2011; 28(4):369-82. PubMed ID: 21809306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase.
    Holleboom AG; Kuivenhoven JA; van Olden CC; Peter J; Schimmel AW; Levels JH; Valentijn RM; Vos P; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Hollak CE
    Atherosclerosis; 2011 May; 216(1):161-5. PubMed ID: 21315357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status of Familial LCAT Deficiency in Japan.
    Kuroda M; Bujo H; Yokote K; Murano T; Yamaguchi T; Ogura M; Ikewaki K; Koseki M; Takeuchi Y; Nakatsuka A; Hori M; Matsuki K; Miida T; Yokoyama S; Wada J; Harada-Shiba M
    J Atheroscler Thromb; 2021 Jul; 28(7):679-691. PubMed ID: 33867422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
    Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
    Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.